Show simple item record

dc.contributor.authorKENNY, ROSEen
dc.contributor.authorHENMAN, MARTINen
dc.date.accessioned2014-08-06T10:10:24Z
dc.date.available2014-08-06T10:10:24Z
dc.date.issued2014en
dc.date.submitted2014en
dc.identifier.citationCousins, G, Galvin, R, Flood, M, Kennedy, MC, Motterlini, N, Henman, MC, Kenny, RA, Fahey, T, Potential for alcohol and drug interactions in older adults: evidence from the Irish longitudinal study on ageing, BMC GERIATRICS, 14, 1, 2014, 57-en
dc.identifier.otherYen
dc.identifier.urihttp://hdl.handle.net/2262/70688
dc.descriptionPUBLISHEDen
dc.description.abstractBackground Older adults are susceptible to adverse effects from the concomitant use of prescription medications and alcohol. This study estimates the prevalence of exposure to alcohol interactive (AI) medications and concomitant alcohol use by therapeutic class in a large, nationally representative sample of older adults. Methods Cross-sectional analysis of a population based sample of older Irish adults aged ≥60 years using data from The Irish Longitudinal Study on Ageing (TILDA) (N = 3,815). AI medications were identified using Stockley’s Drug Interactions, the British National Formulary and the Irish Medicines Formulary. An in-home inventory of medications was used to characterise AI drug exposure by therapeutic class. Self-reported alcohol use was classified as non-drinker, light/moderate and heavy drinking. Comorbidities known to be exacerbated by alcohol were also recorded (diabetes mellitus, hypertension, peptic ulcer disease, liver disease, depression, gout or breast cancer), as well as sociodemographic and health factors. Results Seventy-two per cent of participants were exposed to AI medications, with greatest exposure to cardiovascular and CNS agents. Overall, 60% of participants exposed to AI medications reported concomitant alcohol use, compared with 69.5% of non-AI exposed people (p < 0.001). Almost 28% of those reporting anti-histamine use were identified as heavy drinkers. Similarly almost one in five, combined heavy drinking with anti-coagulants/anti-platelets and cardiovascular agents, with 16% combining heavy drinking with CNS agents. Multinomial logistic regression showed that being male, younger, urban dwelling, with higher levels of education and a history of smoking, were associated with an increased risk for concomitant exposure to alcohol consumption (both light/moderate and heavier) and AI medications. Current smokers and people with increasing co-morbidities were also at greatest risk for heavy drinking in combination with AI medications. Conclusions The concurrent use of alcohol with AI medications, or with conditions known to be exacerbated by alcohol, is common among older Irish adults. Prescribers should be aware of potential interactions, and screen patients for alcohol use and provide warnings to minimize patient risk.en
dc.format.extent57en
dc.language.isoenen
dc.relation.ispartofseriesBMC GERIATRICSen
dc.relation.ispartofseries14en
dc.relation.ispartofseries1en
dc.rightsYen
dc.subjectAgeden
dc.subjectAlcohol drinking/epidemiologyen
dc.subjectAlcohol interactive medicationsen
dc.subjectDrug interactionsen
dc.titlePotential for alcohol and drug interactions in older adults: evidence from the Irish longitudinal study on ageingen
dc.typeJournal Articleen
dc.contributor.sponsorHealth Research Board (HRB)en
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/rkennyen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/mhenmanen
dc.identifier.rssinternalid94747en
dc.identifier.doihttp://dx.doi.org/10.1186/1471-2318-14-57en
dc.rights.ecaccessrightsopenAccess
dc.subject.TCDThemeAgeingen
dc.subject.TCDThemeNeuroscienceen
dc.subject.TCDTagPHARMACY PRACTICEen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record